Literature DB >> 34099937

Detect-seq reveals out-of-protospacer editing and target-strand editing by cytosine base editors.

Zhixin Lei1,2, Haowei Meng3, Zhicong Lv3, Menghao Liu1,2, Huanan Zhao4,5, Hao Wu1,2, Xiaoxue Zhang1,2, Lulu Liu3, Yuan Zhuang3, Kailin Yin3, Yongchang Yan3, Chengqi Yi6,7,8,9.   

Abstract

Cytosine base editors (CBEs) have the potential to correct human pathogenic point mutations. However, their genome-wide specificity remains poorly understood. Here we report Detect-seq for the evaluation of CBE specificity. It enables sensitive detection of CBE-induced off-target sites at the genome-wide level. Detect-seq leverages chemical labeling and biotin pulldown to trace the editing intermediate deoxyuridine, thereby revealing the editome of CBE. In addition to Cas9-independent and typical Cas9-dependent off-target sites, we discovered edits outside the protospacer sequence (that is, out-of-protospacer) and on the target strand (which pairs with the single-guide RNA). Such unexpected off-target edits are prevalent and can exhibit a high editing ratio, while their occurrences exhibit cell-type dependency and cannot be predicted based on the sgRNA sequence. Moreover, we found out-of-protospacer and target-strand edits nearby the on-target sites tested, challenging the general knowledge that CBEs do not induce proximal off-target mutations. Collectively, our approaches allow unbiased analysis of the CBE editome and provide a widely applicable tool for specificity evaluation of various emerging genome editing tools.

Entities:  

Year:  2021        PMID: 34099937     DOI: 10.1038/s41592-021-01172-w

Source DB:  PubMed          Journal:  Nat Methods        ISSN: 1548-7091            Impact factor:   28.547


  39 in total

1.  CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes.

Authors:  Alexis C Komor; Ahmed H Badran; David R Liu
Journal:  Cell       Date:  2017-04-20       Impact factor: 41.582

Review 2.  Gene therapy comes of age.

Authors:  Cynthia E Dunbar; Katherine A High; J Keith Joung; Donald B Kohn; Keiya Ozawa; Michel Sadelain
Journal:  Science       Date:  2018-01-12       Impact factor: 47.728

Review 3.  Recent advances in genome editing of stem cells for drug discovery and therapeutic application.

Authors:  Jaesuk Lee; Delger Bayarsaikhan; Govigerel Bayarsaikhan; Jin-Soo Kim; Elizabeth Schwarzbach; Bonghee Lee
Journal:  Pharmacol Ther       Date:  2020-02-13       Impact factor: 12.310

Review 4.  Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors.

Authors:  Andrew V Anzalone; Luke W Koblan; David R Liu
Journal:  Nat Biotechnol       Date:  2020-06-22       Impact factor: 54.908

Review 5.  CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors.

Authors:  Dan Wang; Feng Zhang; Guangping Gao
Journal:  Cell       Date:  2020-04-02       Impact factor: 41.582

6.  Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems.

Authors:  Keiji Nishida; Takayuki Arazoe; Nozomu Yachie; Satomi Banno; Mika Kakimoto; Mayura Tabata; Masao Mochizuki; Aya Miyabe; Michihiro Araki; Kiyotaka Y Hara; Zenpei Shimatani; Akihiko Kondo
Journal:  Science       Date:  2016-08-04       Impact factor: 47.728

Review 7.  Base editing: precision chemistry on the genome and transcriptome of living cells.

Authors:  Holly A Rees; David R Liu
Journal:  Nat Rev Genet       Date:  2018-12       Impact factor: 53.242

8.  Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage.

Authors:  Nicole M Gaudelli; Alexis C Komor; Holly A Rees; Michael S Packer; Ahmed H Badran; David I Bryson; David R Liu
Journal:  Nature       Date:  2017-10-25       Impact factor: 49.962

9.  Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage.

Authors:  Alexis C Komor; Yongjoo B Kim; Michael S Packer; John A Zuris; David R Liu
Journal:  Nature       Date:  2016-04-20       Impact factor: 49.962

Review 10.  The promise and challenge of therapeutic genome editing.

Authors:  Jennifer A Doudna
Journal:  Nature       Date:  2020-02-12       Impact factor: 49.962

View more
  4 in total

1.  Mitochondrial base editor induces substantial nuclear off-target mutations.

Authors:  Zhixin Lei; Haowei Meng; Lulu Liu; Huanan Zhao; Xichen Rao; Yongchang Yan; Hao Wu; Min Liu; Aibin He; Chengqi Yi
Journal:  Nature       Date:  2022-05-12       Impact factor: 49.962

Review 2.  CRISPR-derived genome editing therapies: Progress from bench to bedside.

Authors:  Holly A Rees; Alex C Minella; Cameron A Burnett; Alexis C Komor; Nicole M Gaudelli
Journal:  Mol Ther       Date:  2021-10-05       Impact factor: 11.454

3.  In Vivo Rapid Investigation of CRISPR-Based Base Editing Components in Escherichia coli (IRI-CCE): A Platform for Evaluating Base Editing Tools and Their Components.

Authors:  Rahul Mahadev Shelake; Dibyajyoti Pramanik; Jae-Yean Kim
Journal:  Int J Mol Sci       Date:  2022-01-20       Impact factor: 5.923

Review 4.  Gene editing and its applications in biomedicine.

Authors:  Guanglei Li; Xiangyang Li; Songkuan Zhuang; Liren Wang; Yifan Zhu; Yangcan Chen; Wen Sun; Zeguang Wu; Zhuo Zhou; Jia Chen; Xingxu Huang; Jin Wang; Dali Li; Wei Li; Haoyi Wang; Wensheng Wei
Journal:  Sci China Life Sci       Date:  2022-02-18       Impact factor: 10.372

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.